None
Quote | Castle Biosciences Inc. (NYSE:CSTL)
Last: | $ |
---|---|
Change Percent: | 4.03% |
Open: | $30.23 |
Close: | $31.47 |
High: | $31.54 |
Low: | $26.39 |
Volume: | 288,453 |
Last Trade Date Time: | 02/12/2020 04:43:13 pm |
News | Castle Biosciences Inc. (NYSE:CSTL)
2024-07-05 12:07:45 ET More on Castle Biosciences Castle Biosciences, Inc. (CSTL) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Castle Biosciences Historical earnings data for Castle Biosciences Financial information for Castle Biosc...
Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE) 1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the lat...
Message Board Posts | Castle Biosciences Inc. (NYSE:CSTL)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
4.03%Change Percent:
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NYSE Market:
Castle Biosciences Inc. Website:
Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE) 1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the lat...
Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and Mississippi Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innova...
Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular Oncology Group (COOG2) Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health ...